Cipla's UK business

GPTKB entity

Statements (50)
Predicate Object
gptkbp:instanceOf gptkb:Company
gptkbp:aimsTo improve access to medicines
gptkbp:collaboratesWith healthcare_providers
gptkbp:contributedTo public health
gptkbp:distributes healthcare_products
gptkbp:employs pharmaceutical professionals
gptkbp:engagesIn research and development
gptkbp:focusesOn generic drugs
gptkbp:hasCollaborationsWith non-profit organizations
research institutions
gptkbp:hasContribution Europe
gptkbp:hasEvents ISO certification
gptkbp:hasFunding biotechnology
gptkbp:hasGoals market expansion
gptkbp:hasHistoricalSignificance gptkb:London
gptkbp:hasPart gptkb:Cipla_UK_Limited
gptkbp:hasParticipatedIn gptkb:NHS
gptkbp:hasPartnershipsWith local distributors
healthcare_organizations
gptkbp:hasProductLine respiratory therapy
gptkbp:hasResearchInterest gptkb:UK
https://www.w3.org/2000/01/rdf-schema#label Cipla's UK business
gptkbp:isActiveIn oncology
gptkbp:isEngagedIn community outreach programs
sustainability initiatives
pharmaceutical education programs
gptkbp:isFocusedOn therapeutic areas
patient-centric solutions
gptkbp:isInvolvedIn patient advocacy
supply chain management
digital health initiatives
healthcare education
UK_regulations
gptkbp:isKnownFor affordable medicines
high-quality generics
supply of essential medicines
gptkbp:isPartOf global pharmaceutical market
Cipla's_corporate_social_responsibility_efforts
Cipla's_global_strategy
gptkbp:isRecognizedBy industry awards
gptkbp:isRecognizedFor innovation in healthcare
gptkbp:isSupportedBy government policies
gptkbp:offers prescription medications
gptkbp:offersServices chronic obstructive pulmonary disease
gptkbp:operatesIn gptkb:United_Kingdom
gptkbp:participatesIn clinical trials
gptkbp:partOf gptkb:Cipla_Limited
gptkbp:provides patient support programs
gptkbp:targets chronic diseases
gptkbp:wasEstablishedIn 2000s